Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.
Karsten
K
Schrör
Prof. Dr. Kurt Huber, 3rd Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria, Tel.: +43 1 4950 2301, Fax: +43 1 4950 2309, E-mail: kurt.huber@meduniwien.ac.at.
Kurt
K
Huber
D054058:Acute Coronary Syndrome / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D003324:Coronary Artery Disease / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018836:Inflammation Mediators; D010975:Platelet Aggregation Inhibitors